Significant Ownership of Redmile Group, LLC

Signature - Title
/s/ Jeremy C. Green - Managing Member
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Redmile Group, LLC.

Notify me when Redmile Group, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Redmile Group, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FATE FATE THERAPEUTICS INC Common Stock, par value $0.001 per share 15% $25,118,211 +$174,923 17,941,579 +0.7% Redmile Group, LLC 02 Jul 2025
ADCT ADC Therapeutics SA Common Shares, par value CHF 0.08 per share 13% $57,966,905 15,666,731 0% Redmile Group, LLC 31 Dec 2025
SRRK Scholar Rock Holding Corporation Common Stock, par value $0.001 per share 9.9% $323,935,513 9,885,124 Redmile Group, LLC 31 Dec 2024
ANNX Annexon, Inc. Common Stock, par value $0.001 per share 9.9% $85,778,935 15,427,866 Redmile Group, LLC 31 Dec 2025
RGNX REGENXBIO Inc. Common Stock, par value $0.0001 per share 9.9% $43,942,300 5,062,477 Redmile Group, LLC 30 Jun 2025
NGNE Neurogene Inc. Common Stock, $0.000001 par value 9.9% $32,077,887 +$1,594,708 1,557,179 +5.2% Redmile Group, LLC 31 Dec 2025
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 9.9% $14,934,463 1,765,303 Redmile Group, LLC 30 Jun 2025
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 9.9% $12,121,231 13,932,449 Redmile Group, LLC 31 Dec 2024
ATRA Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $10,764,875 +$659,400 751,223 +6.5% Redmile Group, LLC 12 Nov 2025
STTK Shattuck Labs, Inc. Common Stock, par value $0.0001 per share 9.9% $5,422,231 +$617,470 6,379,095 +13% Redmile Group, LLC 25 Aug 2025
ALXO ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share 8.5% $2,042,240 4,641,455 Redmile Group, LLC 30 Jun 2025
GRTS Gritstone bio, Inc. Common Stock, $0.0001 par value per share 8.2% $131,635 13,163,457 Redmile Group, LLC 31 Dec 2024
STOK Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share 8% $52,554,931 4,375,931 Redmile Group, LLC 30 Jun 2025
ABSI Absci Corporation Common Stock, $0.0001 par value per share 6.5% $25,255,401 8,335,116 Redmile Group, LLC 25 Apr 2025
IMNM Immunome, Inc. Common Stock, $0.0001 par value per share 5.2% $122,830,910 +$7,672,613 5,718,385 +6.7% Redmile Group, LLC 31 Dec 2025
ZYME Zymeworks Inc. Common Stock, par value $0.00001 per share 4.9% $63,294,210 -$7,598,499 3,705,750 -11% Redmile Group, LLC 30 Sep 2025
PLRX Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.8% $4,545,900 2,895,478 Redmile Group, LLC 31 Dec 2024
SLN Silence Therapeutics plc Ordinary Shares, nominal value GBP 0.05 per share 4.7% 6,644,841 -7.7% Redmile Group, LLC 31 Mar 2025
FOLD Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share 4.6% $106,667,402 14,184,495 Redmile Group, LLC 31 Dec 2024
REPL Replimune Group, Inc. Common Stock, par value $0.001 per share 0.7% $2,245,077 -$18,279,751 535,818 -89% Redmile Group, LLC 30 Sep 2025
IGMS IGM Biosciences, Inc. Common Stock, par value $0.01 per share 0% $0 0 Redmile Group, LLC 14 Aug 2025

Schedules 13D/G Reported by Redmile Group, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.